Holen Sie sich die Stockscreener-App
3.65
1.35%
-0.05
Handel nachbörslich:
3.70
0.05
+1.37%
Schlusskurs vom Vortag:
$3.70
Offen:
$3.65
24-Stunden-Volumen:
53,024
Relative Volume:
0.57
Marktkapitalisierung:
$30.18M
Einnahmen:
$442.00K
Nettoeinkommen (Verlust:
$-30.46M
KGV:
-0.8184
EPS:
-4.46
Netto-Cashflow:
$-27.47M
1W Leistung:
-0.27%
1M Leistung:
+1.67%
6M Leistung:
-19.96%
1J Leistung:
-28.01%
1-Tages-Spanne:
$3.6406
$3.8095
1-Wochen-Bereich:
$3.535
$3.8592
52-Wochen-Spanne:
$2.2801
$6.90
Clene Inc Stock (CLNN) Company Profile
Firmenname
Clene Inc
Sektor
Branche
Telefon
801-676-9695
Adresse
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Vergleichen Sie CLNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
3.65 | 34.31M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
28.02 | 32.47B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
14.55 | 31.36B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
K
Kellanova
|
80.20 | 27.85B | 12.63B | 1.38B | 863.00M | 3.96 |
|
GIS
General Mills Inc
|
49.73 | 26.77B | 19.64B | 2.56B | 2.48B | 4.55 |
|
MKC
Mccormick Co Inc
|
70.62 | 18.70B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-04 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-28 | Eingeleitet | Oppenheimer | Outperform |
Clene Inc Aktie (CLNN) Neueste Nachrichten
| MarketBeat - MarketBeat
Neurodegenerative Disease Treatment Developer Clene Sets Key Investor Update on ALS Progress - Stock Titan
Clene Inc. Equity Warrant Crosses 200 Day MA — Signal or NoiseJuly 2025 Outlook & Free Real-Time Volume Trigger Notifications - 선데이타임즈
Nanomedicines Market from 2025 to 2032: Significant Growth - openPR.com
Why Clene Inc. stock attracts strong analyst attention2025 Earnings Impact & High Return Stock Watch Alerts - newsyoung.net
Clene (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process - The Globe and Mail
Clene Inc. Could See a Relief Rally From SupportROI Boosting Trade Opportunity Calendar Published - beatles.ru
CANACCORD GENUITY GROUP INC. REPORT ON VOTING RESULTS FROM ANNUAL GENERAL MEETING - The Globe and Mail
Piedmont Lithium Announces Updated Timetable for Merger with Sayona Mining - The Globe and Mail
Government Upholds Broken Telecom Regime, Jeopardizing Canada's Prosperity - The Globe and Mail
Clene (NASDAQ: CLNN) To Present At Canaccord 45th Annual Growth Conference - Barchart.com
Clene (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference - The Globe and Mail
Watch for Trend Continuation in Clene Inc. Equity Warrant Next WeekSmart Allocation Growth Setup Plan - beatles.ru
Clene Inc. to Present at Canaccord 45th Annual Growth Conference on August 12, 2025 - Quiver Quantitative
Clene to Present at the Canaccord 45th Annual Growth Conference - The Manila Times
ALS and MS Treatment Developer Clene to Reveal Latest Progress at Major Growth Conference - Stock Titan
TruGolf Holdings Regains Nasdaq Compliance by August 2025 - The Globe and Mail
Sentiment Turns Positive on Clene Inc. — Reversal AheadIntraday Trend Analysis for Fast Gains Released - metal.it
Why Clene Inc. Equity Warrant stock attracts strong analyst attentionConservative Entry for High Return Setup Backed - beatles.ru
What is the risk reward ratio of investing in Clene Inc. stockTriple-digit wealth increases - Jammu Links News
What analysts say about Clene Inc. Equity Warrant stockUnlock expert trading strategies for growth - Jammu Links News
What is Clene Inc. company’s growth strategyMassive profits - Jammu Links News
What is the dividend policy of Clene Inc. stockHigh-velocity capital appreciation - Jammu Links News
Is Clene Inc. a growth stock or a value stockUnprecedented profits - Jammu Links News
Is it the right time to buy Clene Inc. stockOutstanding trading profits - Jammu Links News
What markets is Clene Inc. expanding into Is MURA stock a good long term investment optionCapitalize on market momentum for maximum gains - Jammu Links News
What are analysts’ price targets for Clene Inc. Equity Warrant in the next 12 monthsBuild a portfolio that grows with the market - Jammu Links News
Why is Clene Inc. stock attracting strong analyst attentionDouble-digit growth - Jammu Links News
Is it the right time to buy Clene Inc. Equity Warrant stockRapid growth opportunities - Jammu Links News
How volatile is Clene Inc. Equity Warrant stock compared to the marketAccelerated wealth building - Jammu Links News
What drives Clene Inc. Equity Warrant stock priceCapitalize on high-yield stocks early - Jammu Links News
How does Clene Inc. Equity Warrant compare to its industry peersExceptional stock performance - Jammu Links News
What institutional investors are buying Clene Inc. stockFree Capital Allocation Plans - Jammu Links News
Clene (NASDAQ: CLNN) Reports CNM-Au8 Significantly Improves Survival in ALS Patients - The Globe and Mail
What are Clene Inc. Equity Warrant company’s key revenue driversOutperformance with explosive growth - Jammu Links News
Published on: 2025-08-03 11:24:38 - Jammu Links News
What are the technical indicators suggesting about Clene Inc.Explosive portfolio gains - Jammu Links News
Does Clene Inc. Equity Warrant stock perform well during market downturnsOutstanding investment returns - Jammu Links News
How many analysts rate Clene Inc. as a “Buy”Get real-time alerts on top-performing stocks - Jammu Links News
What drives Clene Inc. stock priceUnbelievable profit margins - Jammu Links News
Is Clene Inc. Equity Warrant a growth stock or a value stockDiscover stocks with strong growth potential - Jammu Links News
What is Clene Inc. Equity Warrant company’s growth strategyCapitalize on fast-growing stocks today - Jammu Links News
What catalysts could drive Clene Inc. Equity Warrant stock higher in 2025Invest smarter with actionable market insights - Jammu Links News
What are the latest earnings results for Clene Inc.Exceptional risk-adjusted gains - Jammu Links News
Published on: 2025-08-03 02:32:15 - Jammu Links News
Clene Inc. Equity Warrant Volume Confirms Breakout — Analysts BullishLow Risk Swing Trade Opportunities Identified - beatles.ru
Will Volume Confirm Reversal in Clene Inc.Community Verified Stock Suggestions Drive Volume - beatles.ru
What is the dividend policy of Clene Inc. Equity Warrant stockWealth Building Guidance For Smart Trading - jammulinksnews.com
Is Clene Inc. stock overvalued or undervaluedValue Investing Tracker To Watch Now - Jammu Links News
Clene Inc. expected to post a loss of 47 cents a shareEarnings Preview - TradingView
Statistical indicators supporting Clene Inc. Equity Warrant’s strengthHigh Yield Stock Screening Results Explained - metal.it
Finanzdaten der Clene Inc-Aktie (CLNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Clene Inc-Aktie (CLNN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| General Resonance LLC | 10% Owner |
Jun 02 '25 |
Sale |
4.12 |
600 |
2,473 |
708,592 |
| General Resonance LLC | 10% Owner |
May 30 '25 |
Sale |
2.80 |
410 |
1,148 |
709,192 |
| General Resonance LLC | 10% Owner |
May 29 '25 |
Sale |
2.73 |
410 |
1,119 |
709,602 |
| General Resonance LLC | 10% Owner |
May 28 '25 |
Sale |
2.60 |
420 |
1,090 |
710,012 |
| General Resonance LLC | 10% Owner |
May 27 '25 |
Sale |
2.45 |
420 |
1,029 |
710,432 |
| General Resonance LLC | 10% Owner |
Mar 19 '25 |
Sale |
4.40 |
1,400 |
6,160 |
710,852 |
| General Resonance LLC | 10% Owner |
Mar 18 '25 |
Sale |
4.45 |
1,333 |
5,932 |
712,252 |
| MATLIN DAVID J | Director |
Sep 30 '24 |
Buy |
4.75 |
92,307 |
438,458 |
444,491 |
| Mortenson Mark | Chief Science Officer |
Sep 30 '24 |
Buy |
4.75 |
20,512 |
97,432 |
28,949 |
| Etherington Robert Dee | Chief Executive Officer |
Sep 30 '24 |
Buy |
4.75 |
10,000 |
47,500 |
40,149 |
1.37%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):